Apremilast as a novel therapeutic option for psoriasis coexisting primary sclerosing cholangitis and ulcerative colitis: A case report
This case underscores the potential response and tolerability of apremilast as an alternative treatment for psoriasis coexisting with autoimmune liver disease and inflammatory bowel disease.
Authors
- Yiyi Wang (ORCID: https://orcid.org/0000-0003-2205-1362)
- Ping Tan (ORCID: https://orcid.org/0000-0002-7445-3577)
- Yue Xiao (ORCID: https://orcid.org/0000-0003-3013-9655)
- Hongxiang Hu (ORCID: https://orcid.org/0000-0002-6221-7462)
- Wenyao Mi (ORCID: https://orcid.org/0000-0002-3263-8020)
- Wei Li (ORCID: https://orcid.org/0000-0002-0746-1091)
- Jingya Gao (ORCID: https://orcid.org/0000-0002-7027-3560)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1097/md.0000000000045232
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00